Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Active Biopsy Guidance System for Oral Lesions
NCT05554133Recruiting
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jun 2023
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by University of Texas MD Anderson Cancer Center. Primary endpoint: Sensitivity and Specificity of the Active Biopsy Guidance System at 1 year. Started Jun 2023; status: recruiting.
Beyond the preview
Go deeper on NCT05554133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05554133.